Q32 Bio Inc. (QTTB) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Q32 Bio reported revenue of $53.7M. Net income was $29.8M (a 55.5% net margin), or $2.42 per diluted share. Operating margin was 31.5%. Operating activities generated -$33.5M of cash. At fiscal year end, Q32 Bio held $61.8M in total assets against $19.8M in total liabilities, including $48.3M of cash and equivalents.
Open the full interactive Q32 Bio financials → Quarterly statements, key ratios, valuation history and price charts.
Q32 Bio Key Stats
| Share Price | $8.06 |
|---|---|
| Market Cap | $164.0M |
| P/E Ratio | 3.3 |
| 52-Week Range | $1.93 – $21.38 |
| Shares Outstanding | 20.3 million (basic, 2026 Q2) |
Q32 Bio Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7M | $34.0M | $3.2M | $1.2M | $0 | $53.7M |
| Operating Income | -$130.3M | -$95.9M | -$133.3M | -$101.4M | -$66.1M | $16.9M |
| Pre-Tax Income | -$128.7M | -$95.8M | $1.2M | -$87.1M | -$46.1M | $29.8M |
| Income Tax | $0 | $0 | $715,000 | $0 | $21,000 | $0 |
| Net Income | -$128.7M | -$95.8M | -$5.0M | -$113.0M | -$47.7M | $29.8M |
| Diluted EPS | -$50.40 | -$31.14 | -$1.62 | -$35.10 | -$6.58 | $2.42 |
Q32 Bio Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $53.7M | $0 | $0 |
| Net Income | -$7.4M | $57.7M | -$7.6M | -$8.9M |
| Diluted EPS | -$0.60 | $4.69 | -$0.54 | -$0.44 |
Q32 Bio Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $217.4M | $108.4M | $34.0M | $39.3M | $78.0M | $48.3M |
| Current Assets | $219.6M | $191.9M | $181.0M | $83.9M | $81.9M | $55.0M |
| Total Assets | $263.7M | $211.7M | $228.5M | $84.6M | $92.3M | $61.8M |
| Current Liabilities | $22.7M | $17.2M | $22.6M | $11.6M | $16.5M | $11.3M |
| Total Long-Term Debt | — | — | — | — | $12.7M | $9.7M |
| Total Liabilities | $67.7M | $42.1M | $50.5M | $11.6M | $86.7M | $19.8M |
| Shareholders' Equity | $196.0M | $169.7M | $178.0M | $73.0M | $5.7M | $42.0M |
Q32 Bio Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$94.3M | -$109.8M | -$113.7M | -$96.2M | -$67.7M | -$33.5M |
| Cash From Investing | $204.9M | -$50.8M | $36.7M | $101.3M | $19.9M | $7.0M |
| Cash From Financing | $53.1M | $52.2M | $596,000 | $184,000 | $95.1M | -$3.1M |
| Free Cash Flow | -$98.1M | -$112.1M | -$114.9M | -$96.5M | -$67.8M | -$33.5M |
Figures from Q32 Bio's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Q32 Bio financials page for every line item.
Q32 Bio Company Profile
| Ticker | QTTB |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Waltham, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001661998 |
Frequently Asked Questions
What was Q32 Bio's revenue in fiscal 2025?
Q32 Bio (QTTB) reported revenue of $53.7M for fiscal 2025.
What is Q32 Bio's annual revenue history?
Q32 Bio's annual revenue by fiscal year: 2020: $2.7M; 2021: $34.0M; 2022: $3.2M; 2023: $1.2M; 2024: $0; 2025: $53.7M.
What was Q32 Bio's net income in fiscal 2025?
Q32 Bio reported net income of $29.8M for fiscal 2025.
What was Q32 Bio's earnings per share (EPS) in fiscal 2025?
Q32 Bio's diluted EPS was $2.42 for fiscal 2025 (adjusted for any later stock splits).
What was Q32 Bio's revenue last quarter?
In its most recent reported quarter (2026 Q2), Q32 Bio reported revenue of $0.
How much debt does Q32 Bio have?
Q32 Bio reported $9.7M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Q32 Bio are outstanding?
Q32 Bio reported a weighted average of 20.3 million basic shares outstanding in 2026 Q2.
What is Q32 Bio's market cap?
Based on its latest closing price, Q32 Bio (QTTB) has a market capitalization of about $164.0M.
When does Q32 Bio's fiscal year end?
Q32 Bio's fiscal year end, as registered with the SEC, is December 31.
Where is Q32 Bio headquartered?
Q32 Bio lists its business address in Waltham, Massachusetts in its SEC filings.